NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 176 filers reported holding NEVRO CORP in Q2 2016. The put-call ratio across all filers is 0.80 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $138,000 | -99.3% | 1,600 | -99.3% | 0.02% | -98.9% |
| Q1 2017 | $20,007,000 | -42.5% | 213,526 | -55.4% | 1.70% | -20.5% |
| Q4 2016 | $34,825,000 | -13.9% | 479,293 | +23.7% | 2.13% | +14.9% |
| Q3 2016 | $40,442,000 | +129.3% | 387,422 | +62.0% | 1.86% | +125.8% |
| Q2 2016 | $17,641,000 | +45.6% | 239,177 | +11.1% | 0.82% | +44.0% |
| Q1 2016 | $12,113,000 | +4.1% | 215,317 | +24.9% | 0.57% | +13.7% |
| Q4 2015 | $11,641,000 | -15.9% | 172,437 | -42.2% | 0.50% | -12.7% |
| Q3 2015 | $13,846,000 | -15.6% | 298,477 | -2.2% | 0.58% | +1.8% |
| Q2 2015 | $16,412,000 | – | 305,341 | – | 0.56% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 1,446,333 | $82,441,000 | 4.44% |
| Asymmetry Capital Management, L.P. | 31,379 | $1,789,000 | 1.65% |
| TIRSCHWELL & LOEWY INC | 194,470 | $11,085,000 | 1.38% |
| ZEVENBERGEN CAPITAL INVESTMENTS LLC | 673,480 | $38,388,000 | 1.22% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 525,040 | $29,927,000 | 1.07% |
| Orbimed Advisors | 1,357,691 | $77,388,000 | 0.93% |
| Sio Capital Management, LLC | 45,091 | $2,570,000 | 0.88% |
| PURA VIDA INVESTMENTS, LLC | 60,000 | $3,420,000 | 0.72% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 159,800 | $9,109,000 | 0.62% |
| Endurant Capital Management LP | 24,171 | $1,378,000 | 0.61% |